Phenoptin meets Phase III endpoints

BioMarin (BMRN; SWX:BMRN) and Merck KGaA (FSE:MRK) said Phenoptin sapropterin in combination with diet

Read the full 145 word article

How to gain access

Continue reading with a
two-week free trial.